| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
0-9 |
GENE |
denotes |
Ubiquitin |
| T1 |
0-30 |
GENE |
denotes |
Ubiquitin specific peptidase 5 |
| T2 |
31-39 |
POSREG |
denotes |
promotes |
| T3 |
40-54 |
DISEASE |
denotes |
ovarian cancer |
| T4 |
60-73 |
CPA |
denotes |
proliferation |
| T5 |
99-104 |
GENE |
denotes |
HDAC2 |
| T6 |
99-104 |
GENE |
denotes |
HDAC2 |
| T7 |
116-141 |
DISEASE |
denotes |
epithelial ovarian cancer |
| T8 |
143-146 |
DISEASE |
denotes |
EOC |
| T9 |
181-191 |
DISEASE |
denotes |
malignancy |
| T10 |
217-227 |
MPA |
denotes |
expression |
| T11 |
251-260 |
GENE |
denotes |
ubiquitin |
| T12 |
251-281 |
GENE |
denotes |
ubiquitin specific peptidase 5 |
| T13 |
283-287 |
GENE |
denotes |
USP5 |
| T14 |
319-326 |
DISEASE |
denotes |
cancers |
| T15 |
334-337 |
DISEASE |
denotes |
EOC |
| T16 |
361-365 |
GENE |
denotes |
USP5 |
| T17 |
366-379 |
VAR |
denotes |
amplification |
| T18 |
391-400 |
REG |
denotes |
prevalent |
| T19 |
418-421 |
DISEASE |
denotes |
EOC |
| T20 |
426-436 |
REG |
denotes |
associated |
| T21 |
442-448 |
POSREG |
denotes |
higher |
| T22 |
454-464 |
MPA |
denotes |
expression |
| T23 |
468-472 |
GENE |
denotes |
USP5 |
| T24 |
474-478 |
GENE |
denotes |
USP5 |
| T25 |
479-492 |
VAR |
denotes |
amplification |
| T26 |
497-511 |
VAR |
denotes |
overexpression |
| T27 |
516-526 |
POSREG |
denotes |
positively |
| T28 |
527-537 |
REG |
denotes |
correlated |
| T29 |
543-547 |
NEGREG |
denotes |
poor |
| T30 |
548-557 |
CPA |
denotes |
prognosis |
| T31 |
573-598 |
DISEASE |
denotes |
ovarian serous carcinomas |
| T32 |
600-610 |
VAR |
denotes |
Disruption |
| T33 |
614-618 |
GENE |
denotes |
USP5 |
| T34 |
630-639 |
NEGREG |
denotes |
repressed |
| T35 |
640-658 |
CPA |
denotes |
cell proliferation |
| T36 |
662-670 |
POSREG |
denotes |
inducing |
| T37 |
671-700 |
CPA |
denotes |
cell cycle G0/G1 phase arrest |
| T38 |
704-718 |
DISEASE |
denotes |
ovarian cancer |
| T39 |
740-744 |
GENE |
denotes |
USP5 |
| T40 |
745-754 |
VAR |
denotes |
knockdown |
| T41 |
755-764 |
NEGREG |
denotes |
inhibited |
| T42 |
765-781 |
CPA |
denotes |
xenograft growth |
| T43 |
796-805 |
VAR |
denotes |
Knockdown |
| T44 |
809-813 |
GENE |
denotes |
USP5 |
| T45 |
814-823 |
NEGREG |
denotes |
decreased |
| T46 |
824-843 |
GENE |
denotes |
histone deacetylase |
| T47 |
824-845 |
GENE |
denotes |
histone deacetylase 2 |
| T48 |
832-845 |
GENE |
denotes |
deacetylase 2 |
| T49 |
847-852 |
GENE |
denotes |
HDAC2 |
| T50 |
854-864 |
MPA |
denotes |
expression |
| T51 |
869-878 |
POSREG |
denotes |
increased |
| T52 |
879-882 |
GENE |
denotes |
p27 |
| T53 |
919-929 |
MPA |
denotes |
expression |
| T54 |
956-965 |
POSREG |
denotes |
promoting |
| T55 |
977-981 |
GENE |
denotes |
USP5 |
| T56 |
982-996 |
VAR |
denotes |
overexpression |
| T57 |
1005-1018 |
CPA |
denotes |
proliferation |
| T58 |
1023-1044 |
CPA |
denotes |
cell cycle transition |
| T59 |
1061-1071 |
NEGREG |
denotes |
inhibitory |
| T60 |
1083-1087 |
GENE |
denotes |
USP5 |
| T61 |
1088-1102 |
VAR |
denotes |
overexpression |
| T62 |
1106-1109 |
GENE |
denotes |
p27 |
| T63 |
1110-1120 |
MPA |
denotes |
expression |
| T64 |
1126-1134 |
REG |
denotes |
mediated |
| T65 |
1138-1143 |
GENE |
denotes |
HDAC2 |
| T66 |
1155-1159 |
GENE |
denotes |
USP5 |
| T67 |
1160-1170 |
INTERACTION |
denotes |
interacted |
| T68 |
1176-1181 |
GENE |
denotes |
HDAC2 |
| T69 |
1176-1181 |
GENE |
denotes |
HDAC2 |
| T70 |
1187-1197 |
VAR |
denotes |
disruption |
| T71 |
1201-1205 |
GENE |
denotes |
USP5 |
| T72 |
1206-1214 |
POSREG |
denotes |
enhanced |
| T73 |
1219-1233 |
MPA |
denotes |
ubiquitination |
| T74 |
1237-1242 |
GENE |
denotes |
HDAC2 |
| T75 |
1237-1242 |
GENE |
denotes |
HDAC2 |
| T76 |
1244-1257 |
GENE |
denotes |
HDAC2 protein |
| T77 |
1244-1249 |
GENE |
denotes |
HDAC2 |
| T78 |
1284-1296 |
GENE |
denotes |
USP5 protein |
| T79 |
1284-1288 |
GENE |
denotes |
USP5 |
| T80 |
1302-1312 |
NEGREG |
denotes |
negatively |
| T81 |
1329-1340 |
GENE |
denotes |
p27 protein |
| T82 |
1329-1332 |
GENE |
denotes |
p27 |
| T83 |
1344-1369 |
DISEASE |
denotes |
ovarian serous carcinomas |
| T84 |
1414-1423 |
POSREG |
denotes |
oncogenic |
| T85 |
1436-1440 |
GENE |
denotes |
USP5 |
| T86 |
1484-1506 |
DISEASE |
denotes |
ovarian carcinogenesis |
| R26 |
T31 |
T27 |
ThemeOf |
ovarian serous carcinomas,positively |
| R27 |
T31 |
T28 |
ThemeOf |
ovarian serous carcinomas,correlated |
| R28 |
T31 |
T29 |
ThemeOf |
ovarian serous carcinomas,poor |
| R29 |
T31 |
T30 |
ThemeOf |
ovarian serous carcinomas,prognosis |
| R30 |
T32 |
T34 |
CauseOf |
Disruption,repressed |
| R31 |
T32 |
T36 |
CauseOf |
Disruption,inducing |
| R32 |
T33 |
T32 |
ThemeOf |
USP5,Disruption |
| R33 |
T34 |
T36 |
CauseOf |
repressed,inducing |
| R34 |
T35 |
T34 |
ThemeOf |
cell proliferation,repressed |
| R35 |
T37 |
T36 |
ThemeOf |
cell cycle G0/G1 phase arrest,inducing |
| R36 |
T38 |
T34 |
ThemeOf |
ovarian cancer,repressed |
| R37 |
T38 |
T36 |
ThemeOf |
ovarian cancer,inducing |
| R38 |
T38 |
T37 |
ThemeOf |
ovarian cancer,cell cycle G0/G1 phase arrest |
| R39 |
T39 |
T40 |
ThemeOf |
USP5,knockdown |
| R0 |
T3 |
T2 |
ThemeOf |
ovarian cancer,promotes |
| R1 |
T3 |
T4 |
ThemeOf |
ovarian cancer,proliferation |
| R2 |
T4 |
T2 |
ThemeOf |
proliferation,promotes |
| R3 |
T11 |
T10 |
ThemeOf |
ubiquitin,expression |
| R4 |
T13 |
T10 |
ThemeOf |
USP5,expression |
| R5 |
T15 |
T10 |
ThemeOf |
EOC,expression |
| R6 |
T16 |
T17 |
ThemeOf |
USP5,amplification |
| R7 |
T17 |
T18 |
CauseOf |
amplification,prevalent |
| R8 |
T19 |
T18 |
ThemeOf |
EOC,prevalent |
| R9 |
T19 |
T20 |
ThemeOf |
EOC,associated |
| R10 |
T19 |
T21 |
ThemeOf |
EOC,higher |
| R11 |
T22 |
T21 |
ThemeOf |
expression,higher |
| R12 |
T22 |
T20 |
ThemeOf |
expression,associated |
| R13 |
T23 |
T22 |
ThemeOf |
USP5,expression |
| R14 |
T23 |
T21 |
ThemeOf |
USP5,higher |
| R15 |
T24 |
T25 |
ThemeOf |
USP5,amplification |
| R16 |
T25 |
T27 |
CauseOf |
amplification,positively |
| R17 |
T25 |
T28 |
CauseOf |
amplification,correlated |
| R18 |
T25 |
T29 |
CauseOf |
amplification,poor |
| R19 |
T26 |
T27 |
CauseOf |
overexpression,positively |
| R20 |
T26 |
T28 |
CauseOf |
overexpression,correlated |
| R21 |
T26 |
T29 |
CauseOf |
overexpression,poor |
| R22 |
T27 |
T28 |
ThemeOf |
positively,correlated |
| R23 |
T30 |
T29 |
ThemeOf |
prognosis,poor |
| R24 |
T30 |
T27 |
ThemeOf |
prognosis,positively |
| R25 |
T30 |
T28 |
ThemeOf |
prognosis,correlated |
| R40 |
T40 |
T41 |
CauseOf |
knockdown,inhibited |
| R41 |
T42 |
T41 |
ThemeOf |
xenograft growth,inhibited |
| R42 |
T43 |
T45 |
CauseOf |
Knockdown,decreased |
| R43 |
T43 |
T51 |
CauseOf |
Knockdown,increased |
| R44 |
T44 |
T43 |
ThemeOf |
USP5,Knockdown |
| R45 |
T44 |
T50 |
ThemeOf |
USP5,expression |
| R46 |
T46 |
T45 |
ThemeOf |
histone deacetylase,decreased |
| R47 |
T46 |
T50 |
ThemeOf |
histone deacetylase,expression |
| R48 |
T48 |
T45 |
ThemeOf |
deacetylase 2,decreased |
| R49 |
T48 |
T50 |
ThemeOf |
deacetylase 2,expression |
| R50 |
T49 |
T43 |
ThemeOf |
HDAC2,Knockdown |
| R51 |
T49 |
T45 |
ThemeOf |
HDAC2,decreased |
| R52 |
T49 |
T50 |
ThemeOf |
HDAC2,expression |
| R53 |
T50 |
T45 |
ThemeOf |
expression,decreased |
| R54 |
T52 |
T53 |
ThemeOf |
p27,expression |
| R55 |
T53 |
T51 |
ThemeOf |
expression,increased |
| R56 |
T55 |
T56 |
ThemeOf |
USP5,overexpression |
| R57 |
T56 |
T54 |
CauseOf |
overexpression,promoting |
| R58 |
T56 |
T59 |
CauseOf |
overexpression,inhibitory |
| R59 |
T57 |
T56 |
ThemeOf |
proliferation,overexpression |
| R60 |
T57 |
T59 |
ThemeOf |
proliferation,inhibitory |
| R61 |
T57 |
T64 |
ThemeOf |
proliferation,mediated |
| R62 |
T58 |
T64 |
ThemeOf |
cell cycle transition,mediated |
| R63 |
T59 |
T54 |
CauseOf |
inhibitory,promoting |
| R64 |
T60 |
T61 |
ThemeOf |
USP5,overexpression |
| R65 |
T60 |
T63 |
ThemeOf |
USP5,expression |
| R66 |
T60 |
T64 |
ThemeOf |
USP5,mediated |
| R67 |
T61 |
T54 |
CauseOf |
overexpression,promoting |
| R68 |
T61 |
T59 |
CauseOf |
overexpression,inhibitory |
| R69 |
T63 |
T61 |
ThemeOf |
expression,overexpression |
| R70 |
T61 |
T64 |
ThemeOf |
overexpression,mediated |
| R71 |
T63 |
T59 |
ThemeOf |
expression,inhibitory |
| R72 |
T63 |
T64 |
ThemeOf |
expression,mediated |
| R73 |
T65 |
T64 |
ThemeOf |
HDAC2,mediated |
| R74 |
T66 |
T67 |
ThemeOf |
USP5,interacted |
| R75 |
T66 |
T70 |
ThemeOf |
USP5,disruption |
| R76 |
T68 |
T67 |
ThemeOf |
HDAC2,interacted |
| R77 |
T70 |
T72 |
CauseOf |
disruption,enhanced |
| R78 |
T71 |
T70 |
ThemeOf |
USP5,disruption |
| R79 |
T73 |
T72 |
ThemeOf |
ubiquitination,enhanced |
| R80 |
T74 |
T73 |
ThemeOf |
HDAC2,ubiquitination |
| R81 |
T76 |
T80 |
ThemeOf |
HDAC2 protein,negatively |
| R82 |
T81 |
T80 |
ThemeOf |
p27 protein,negatively |
| R83 |
T83 |
T80 |
ThemeOf |
ovarian serous carcinomas,negatively |
| R84 |
T85 |
T84 |
ThemeOf |
USP5,oncogenic |
